Spero Therapeutics secures $105M royalty-backed financing deal
Go back to Spero Therapeutics secures $105M royalty-backed financing deal| KKR & CO. L.P. (NYSE: KKR) | Delayed: 89.87 +0.66 (0.74%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $89.21 | 52 Week High | $17.84 | |||
| Open | $90.66 | 52 Week Low | $10.89 | |||
| Day High | $91.00 | P/E | 39.07 | |||
| Day Low | $89.00 | EPS | $2.30 | |||
| Volume | 5,696,158 | |||||
| SmartPros Ltd. (NASDAQ: SPRO) | Delayed: 1.17 -0.05 (4.1%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.22 | 52 Week High | $3.85 | |||
| Open | $1.21 | 52 Week Low | $1.25 | |||
| Day High | $1.22 | P/E | N/A | |||
| Day Low | $1.17 | EPS | $-0.28 | |||
| Volume | 265,712 | |||||



